- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
AusBiotech welcomes a legislative Bill that has been introduced into the
Australian Parliament today - The Intellectual Property Laws Amendment
(Raising the Bar) Bill 2011.
AusBiotech confirms its support in general for this package of
intellectual property reform developed by IP Australia and contained in
the 'Raising the Bar' Bill. Specifically, AusBiotech is in favour of a
broad research use exemption from patent infringement becoming enshrined
in Australia's patent law so this country's researchers and industry may
be confident as they strive to innovate.
In its recent submission to the Senate Inquiry into the Patent Amendment
(Human Genes & Biological Materials) Bill 2010, AusBiotech stated its
belief that the thresholds for patentability should be properly set and
rigorously applied across all forms of invention, ie: in a
technology-neutral manner. AusBiotech has publicly and strongly opposed
the Patent Amendment (Human Genes & Biological Materials) Bill 2010, as
it completely fails to address any of the community's valid concerns and
threatens scientific research and development on biological materials.
AusBiotech is instead in favour of the Government's 'Raising the Bar'
Bill which, when taken together with the erudite recommendations from
the Australian Law Reform Commission 1999 report, the Senate Inquiry
into Gene Patents (2010) and the Advisory Council on Intellectual
Property 2010 review will deliver the solutions to address the issues
identified by clinicians, researchers, industry and the community.
AusBiotech strongly encourages the Australian Parliament to support the
Bill so that the many consequential benefits of the law reform can be
Dr Anna Lavelle, CEO of AusBiotech said: "Two years of consultation and
deliberation that has resulted in the "Raising the Bar' Bill, will
guarantee a strengthening of Australia's IP management system."
AusBiotech is Australia's voice on biotechnology, and represents more
than 3,000 members, encompassing medicines, medical diagnostics and
devices, agriculture, alternative fuels and climate change.
For more information, please click here
03 9828 1414 / 0429 801118
Copyright © AusBiotechIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
A compact, efficient single photon source that operates at ambient temperatures on a chip: Highly directional single photon source concept is expected to lead to a significant progress in producing compact, cheap, and efficient sources of quantum information bits for future appls May 3rd, 2016
Correction: Solar fuels: Protective layer for the 'artificial leaf' March 22nd, 2016